About Us > Kris Conner

Kris Conner

Kris Conner

Highlights

  • Contributing writer since 2019
  • Writes extensively about breast cancer for many print publications and websites.
featured_paragraph

Kris coauthored a patient guide on ovarian cancer that was recognized for excellence by the American Medical Writers Association.

general_content

In addition to her patient education writing, Kris works on strategic marketing and fundraising communications for colleges and schools, healthcare systems, foundations, and other nonprofit organizations.

contributions_carousel

Contributions

Making an informed choice about hormonal therapy: Laura-Lynn Renner

08/07/24 | BY: Kris Conner

Laura-Lynn Renner was struggling with hormonal treatments until the Mammaprint test gave her the confidence to make informed health choices, transforming her breast cancer journey and improving her quality of life.

Read More
 | 7 Min. Read |

Taking charge and finding new treatment options for MBC: Tammy Uhl

06/20/24 | BY: Kris Conner

After assembling the right care team for her, Tammy Uhl learned about a new type of PET scan that completely changed her treatment plan for metastatic breast cancer.

Read More
 | 7 Min. Read |

Getting “science-driven” care for metastatic breast cancer

10/11/23 | BY: MJ Borrelli*, Kris Conner

MJ Borrelli shares how genomic testing informed her treatment decisions—and why she recommends anyone with metastatic breast cancer ask for testing and advocate for themselves.

Read More
 | 8 Min. Read |

Circulating tumor DNA tests for peace of mind: Chloë Crampton

03/30/23 | BY: Kris Conner, Chloë Crampton

Diagnosed with triple-negative breast cancer in 2021, actor-turned-celebrity-chef Chloë Crampton shares her decision-making process around monitoring for cancer recurrence with liquid biopsy tests.

Read More
 | 10 Min. Read |

From fear to knowledge: Tianna Wayns’ journey to genetic testing

12/08/21 | BY: Kris Conner

Tianna Wayns shares her family’s genetic testing experience and why she chose to test.

Read More
 | 9 Min. Read

More Women Should Be Considered for BRCA Testing, Task Force Says

12/05/19 | BY: Kris Conner

The U.S. Preventive Services Task Force issued updated genetic testing guidelines in August 2019.

Read More
 | 9 Min. Read

FDA Approves Trastuzumab Shots for Certain HER2-Positive Breast Cancers

07/12/19 | BY: Kris Conner

Unlike traditional IV trastuzumab (Herceptin), the combination of trastuzumab and hyaluronidase-oyst (Herceptin Hylecta) can be injected under the skin, making treatments quicker

Read More
 | 8 Min. Read